Subcutaneous
See also: intramuscularintravenousbioavailability
Subcutaneous (SC) refers to administration of a substance into the tissue layer between the skin and the muscle (subcutis). This is a common route of administration for peptides in research settings, offering slower absorption than intravenous (IV) but generally faster than intramuscular (IM) injection.
Key Points
- Absorption Rate: Slower than IV, faster than IM
- Onset: Typically 15-30 minutes for many peptides
- Duration: Often 2-4 hours depending on peptide
- Common Sites: Abdomen, thigh, upper arm
- Volume Limits: Typically 1-2 mL per injection site
Research Context
In peptide research, subcutaneous administration is frequently studied because it:
- Mimics common clinical administration routes
- Provides consistent, measurable absorption profiles
- Allows for controlled, sustained release in many formulations
- Is less invasive than IV but more convenient than IM for self-administration in research models
Safety Considerations
- Injection technique and site rotation are important to prevent tissue damage
- Absorption rates can vary significantly between individuals
- Local reactions (redness, swelling) are common in research settings
- Sterile technique is essential to prevent infection
Note: This term describes an administration route, not a recommendation. Always follow approved protocols and institutional guidelines for research procedures.